Profile data is unavailable for this security.
About the company
Shanghai Pharmaceuticals Holding Co Ltd is a China-based company mainly engaged in pharmaceutical distribution business. The Company mainly operates four business segments. The Industrial segment is mainly engaged in the research and development, production, and sales of drugs and health products. The Distribution segment is mainly engaged in providing distribution, warehousing, and other value-added pharmaceutical supply chain solutions and related services to pharmaceutical manufacturers and distributors. The Retail segment is mainly engaged in operating and franchising the retail pharmacy network. The Others segment mainly engage in other businesses. The Company mainly operates its businesses in the domestic market.
- Revenue in CNY (TTM)280.69bn
- Net income in CNY5.65bn
- Incorporated1994
- Employees49.40k
- LocationShanghai Pharmaceuticals Holding Co LtdShanghai Pharmaceutical MansionNo.200 Taicang RoadSHANGHAI 200020ChinaCHN
- Phone+86 2 163730908
- Fax+86 2 163289333
- Websitehttps://www.sphchina.com/
| Holder | Shares | % Held |
|---|---|---|
| New China Asset Management Co., Ltd.as of 30 Jun 2025 | 182.72m | 6.55% |
| E Fund Management Co., Ltd.as of 30 Jun 2025 | 25.28m | 0.91% |
| Huatai-PineBridge Fund Management Co., Ltd.as of 30 Jun 2025 | 15.90m | 0.57% |
| China Universal Asset Management Co., Ltd.as of 30 Jun 2025 | 14.65m | 0.53% |
| Harvest Fund Management Co., Ltd.as of 30 Jun 2025 | 12.01m | 0.43% |
| ICBC UBS Asset Management Co. Ltd.as of 30 Jun 2025 | 9.55m | 0.34% |
| China Asset Management Co., Ltd.as of 30 Jun 2025 | 8.53m | 0.31% |
| The Vanguard Group, Inc.as of 04 Feb 2026 | 7.11m | 0.26% |
| Norges Bank Investment Managementas of 30 Jun 2025 | 5.56m | 0.20% |
| HuaAn Fund Management Co., Ltd.as of 30 Jun 2025 | 4.68m | 0.17% |
